Loading stock data...
C4 Therapeutics, Inc. (CCCC) Stock Price, Chart & Analysis
C4 Therapeutics, Inc.CCCC
Market Closed$2.12
+$0.07+3.41%
CCCC Market Indicators
Very Bearish
Market Sentiment
Historical Price Chart
View the historical price chart for CCCC to analyze trends and spot opportunities. Use our interactive chart to compare past performance and make informed decisions.
C4 Therapeutics, Inc. (CCCC)
Loading chart data...
Is C4 Therapeutics, Inc. (CCCC) Stock a Buy in 2025?
YES
STRONG BUY
Score: 93/100
Yes, CCCC stock appears to be a good buy in 2025 based on our comprehensive analysis.
Comprehensive analysis of whether CCCC stock is a good investment in 2025, including growth drivers, valuation metrics, risk factors, and analyst recommendations.
Growth Drivers
- Strong revenue growth of 71.4%
- Healthcare sector momentum
Valuation Considerations
- Analyst price targets suggest 645.3% upside potential
- Small-cap with higher growth potential and volatility
Risk Factors
- High debt-to-equity ratio of 32.98
- Healthcare sector cyclicality
- Small-cap liquidity and volatility risks
Analyst Consensus
Buy Ratings:2
Hold Ratings:3
Sell Ratings:0
Avg. Price Target:$15.80
Upside Potential:645.3%
Investment Summary
CCCC presents a mixed investment profile for 2025. The company shows strong growth drivers including strong revenue growth of 71.4%, though analyst price targets suggest 645.3% upside potential.
Analyst sentiment is generally positive with 2 buy ratings vs 0 sell ratings.
Investors should weigh the growth potential against the identified risks, particularly high debt-to-equity ratio of 32.98, and consider their own risk tolerance and investment timeline.
Final Recommendation
STRONG BUY
Recommendation Score
Overall Score:93/100
Strong Buy
2030 Price Prediction
Predicted Price:$6.47
Potential Return:+205.2%
Key Factors
- Exceptional revenue growth
- Moderate analyst support
- Very significant upside potential
- Exceptional long-term growth potential to 2030
- Wide analyst target range indicates uncertainty
- Debt-to-Market-Cap Ratio: 42.8% (Moderate)
Investment Decision
Based on our comprehensive analysis of CCCC's financial metrics, growth prospects, valuation, analyst sentiment, and risk factors, we recommend a STRONG BUY. This recommendation considers the company's current fundamentals, market position, and future growth potential while accounting for identified risks and market conditions.
cccc Stock Price Prediction 2030
Predicted 2030 Price
$6.47
+205.2%from current price
Based on revenue growth analysis and market trends, cccc stock is projected to reach $6.47 by 2030, representing a 205.2% increase from the current price of $2.12.
Current Price
$2.12
Revenue Growth
138.2%
Analyst Target
$15.80
View Full Prediction Analysis
Get detailed analyst targets, key factors, and comprehensive forecast analysis
How to Invest in cccc Stock?
Quick Investment Insights for cccc
High Volatility (Beta: 2.96)
1. Research Fundamentals
Analyze financial statements and market position
2. Technical Analysis
Review price charts and technical indicators
3. Risk Assessment
Evaluate market and company-specific risks
Company Profile
C4 Therapeutics, Inc.
Healthcare
Biotechnology
C4 Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel therapeutic candidates to degrade disease-causing proteins. Its lead product candidate is Cemsidomide, an orally bioav...
Employees
110
Market Cap
$150.54M